Last reviewed · How we verify
NCT03630510
Ventilator Hyperinflation With Increase of Inspiratory Time
NA trial testing Ventilator hyperinflation in Lung Infection in 38 participants. Completed in 28 March 2018.
12 August 2017
Quick facts
| Lead sponsor | Brazilian Institute of Higher Education of Censa |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 38 |
| Start date | 18 March 2017 |
| Primary completion | 12 August 2017 |
| Estimated completion | 28 March 2018 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- Ventilator hyperinflation
Conditions studied
- Lung Infection — all drugs for Lung Infection →
- Mechanical Ventilation — all drugs for Mechanical Ventilation →
Sponsor
Brazilian Institute of Higher Education of Censa
Who can join
Adults 18 to 80, any sex, with Lung Infection or Mechanical Ventilation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators hypothesis is that the adjustment of the inspiratory time may optimize the distribution of ventilation and increase tidal volume, producing potential therapeutic effects on the displacement of secretions and respiratory mechanics. The objective of this study was To evaluate the effects of hyperinflation with the ventilator associated with increased inspiratory time on respiratory mechanics.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Acute effects of ventilator hyperinflation with increased inspiratory time on respiratory mechanics: randomized crossover clinical trial.
Chicayban LM. · · 2019 · cited 5× · PMID 31618346 · DOI 10.5935/0103-507x.20190052
Verify or expand the search:
- PubMed search for NCT03630510
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Lung Infection
Currently open trials in the same condition.
- NCT06970262 — FMT for Lung and Associated-organ Rescue Efficacy in ARDS Patients · NA · recruiting
- NCT06648317 — Radiolabelled Nectin-4 Targeted LMW Probe PET/CT in Patients With Lung Lesions · recruiting
- NCT06528418 — Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath · recruiting
- NCT05973201 — Evaluation of Virtual Reality to Reduce Anxiety, Pain and Duration of Non-emergency Vigile Bronchial Fibroscopy (AVATAR) · NA · recruiting
- NCT06106789 — A Study of the Clinical Benefit of Tobramycin Inhalation Solution · active not recruiting
Other Brazilian Institute of Higher Education of Censa trials
Trials by the same sponsor.
- NCT04924816 — Awake Prone Position in Patients With COVID-19 · completed
- NCT04012489 — Breath and Air Stacking on Respiratory Mechanics in Tracheostomized Patients · NA · completed
- NCT03631342 — Comparison Between Different Ventilator Hyperinflation Maneuvers · NA · completed
- NCT03630484 — Ventilator Hyperinflation and Manual Rib Cage Compression · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03630510 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Brazilian Institute of Higher Education of Censa
- Last refreshed: 15 August 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03630510.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing